MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study

    N. Del Campo, P. Péran, P. Payoux, V. Rousseau, A. Drif, H. Catalá, C. Thalamas, C. Tranchant, F. Duriff, A. Marques, JP. Azulay, C. Moreau, JC. Corvol, S. Thobois, AG. Corbille, S. Frismand, B. Patterson, A. Foubert-Samier, A. Pavy-Letraon, M. Fabbri, W. Meissner, O. Rascol (Toulouse, France)

    Objective: To evaluate multiple system atrophy (MSA) disease progression on a panel of candidate MSA biomarkers pre-selected for their putative involvement in the pathophysiology of…
  • 2023 International Congress

    Sacral Mass Lesion Mimicking Atypical Foot Dystonia In Parkinsonian Patient

    B. Barton (CHICAGO, USA)

    Objective: Describe an unusual presentation of leg posturing and dystonic features in a patient with diagnosis of atypical parkinsonism, which was ultimately found to be…
  • 2023 International Congress

    Association Between Anticholinergic Burden, MCI, and Cholinergic Denervation

    R. Paalanen, S. Roytman, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To characterize the relationship between anticholinergic burden (ACB), mild cognitive impairment (MCI), and its underlying cholinergic pathology. Background: MCI is a common phenomenon in…
  • 2023 International Congress

    Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease

    EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga (MÉXICO, Mexico)

    Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    Clinical toolkits to improve conversations about Parkinson’s dementia

    I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

    Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…
  • 2023 International Congress

    Clinical correlates of olfactory dysfunction in Huntington’s disease

    N. Rocha, J. Patino, S. Abdollah Zadegan, H. Coco, A. Liang, F. Ramirez, E. Furr Stimming (Houston, USA)

    Objective: To assess olfactory dysfunction in patients with HD and correlate the degree of olfactory dysfunction with symptomatic domains of HD. Background: Olfactory dysfunction is…
  • 2023 International Congress

    Machine Learning Prediction of Gait Dysfunction from DTI Multi-Spectral Diffusion Weighted Imaging ROIs

    C. Raimondo, I. Ailes, I. Shelley, K. Shivok, M. Syed, M. Alizadeh (Philadelphia, USA)

    Objective: To compare the performance of various machine learning techniques, including LDA, k-NN, SVM, MLP, Long Short-Term Memory (LSTM), Gradient Boosting Machines (GBM), Random Forest,…
  • 2023 International Congress

    Modifying clinical and electrophysiological parameters through Transcranial pulsed current stimulation (tPCS) in Huntington disease

    M. Tuesta Bernaola, J. Ganguly, A. Parra Peña, M. Jog (London, Canada)

    Objective: 1. To assess brain network dysfunction of Huntington disease (HD). 2. To evaluate the effectiveness of 2-week home-based chronic non-invasive transcranial brain stimulation to…
  • « Previous Page
  • 1
  • …
  • 493
  • 494
  • 495
  • 496
  • 497
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley